| |
| |
|
| Insider
Information: |
Roberts Bryan E |
| Relationship: |
|
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
9 |
|
| Direct
Shares |
133,663 |
|
|
Indirect Shares
|
17,084,048 |
|
|
| Direct
Value |
$207,362 |
|
|
|
Indirect Value
|
$667,770,104 |
|
|
| Total
Shares |
17,217,711 |
|
|
| Total
Value |
$667,977,466 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Xenoport Inc |
XNPT |
Director |
2007-05-10 |
5 |
2007-05-10 |
1,022,233 |
Premium* |
|
|
Neurocrine Biosciences Inc |
NBIX |
10% Owner |
|
0 |
2009-12-22 |
4,784,689 |
Premium* |
|
|
Ironwood Pharmaceuticals Inc |
IRWD |
Director |
2015-06-15 |
31,951 |
2015-06-15 |
92,027 |
Premium* |
|
|
Chelsea Therapeutics Internation... |
CHTP |
10% Owner |
2010-09-20 |
0 |
2011-02-02 |
5,189,934 |
Premium* |
|
|
Zeltiq Aesthetics Inc |
ZLTQ |
Director |
2015-11-04 |
13,204 |
2015-11-04 |
0 |
Premium* |
|
|
Achaogen Inc |
AKAO |
Director, 10% Owner |
2014-03-17 |
0 |
2014-03-17 |
1,746,461 |
Premium* |
|
|
Vitae Pharmaceuticals, Inc |
VTAE |
Director, 10% Owner |
2014-09-29 |
0 |
2014-09-29 |
47,077 |
Premium* |
|
|
Castlight Health, Inc. |
CSLT |
Director, 10% Owner |
2022-02-17 |
0 |
2022-02-17 |
0 |
Premium* |
|
|
10x Genomics, Inc. |
TXG |
|
2023-06-14 |
88,503 |
2023-06-14 |
4,201,627 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
122 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TXG |
10x Genomics, Inc. |
Director |
– • – |
2020-12-10 |
4 |
D |
$0.00 |
$0 |
I/I |
(268,692) |
2,037,825 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
Director |
– • – |
2021-04-30 |
4 |
A |
$0.00 |
$0 |
I/I |
2,000,000 |
2,037,825 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
Director |
– • – |
2020-05-01 |
4 |
A |
$0.00 |
$0 |
I/I |
1,931,737 |
2,231,737 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
Director |
– • – |
2020-12-08 |
4 |
D |
$0.00 |
$0 |
I/I |
(731,308) |
2,306,517 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
Director |
– • – |
2020-12-08 |
4 |
A |
$0.00 |
$0 |
I/I |
3,000,000 |
3,037,825 |
0 |
- |
|
| ZLTQ |
Zeltiq Aesthetics Inc |
Director |
– • – |
2014-01-23 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,000,000) |
3,458,233 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
|
• • – |
2023-05-17 |
4 |
A |
$0.00 |
$0 |
I/I |
3,790,422 |
3,790,422 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
Director |
– • – |
2020-05-20 |
4 |
A |
$0.00 |
$0 |
I/I |
2,156,088 |
4,387,825 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
10% Owner |
– – • |
2009-12-22 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
4,784,689 |
|
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2011-02-02 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,114,934 |
|
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2011-02-02 |
4 |
B |
$5.00 |
$374,993 |
I/I |
75,000 |
5,189,934 |
1.5 |
- |
|
| CSLT |
Castlight Health, Inc. |
Director |
– • • |
2017-04-03 |
4 |
A |
$0.00 |
$0 |
I/I |
3,965,979 |
5,222,709 |
0 |
- |
|
| ZLTQ |
Zeltiq Aesthetics Inc |
Director |
– • • |
2011-10-18 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,230,627 |
|
- |
|
| ZLTQ |
Zeltiq Aesthetics Inc |
Director |
– • • |
2012-06-13 |
4 |
B |
$4.51 |
$89,728 |
I/I |
19,879 |
5,250,506 |
2.25 |
- |
|
| CSLT |
Castlight Health, Inc. |
Director |
– • • |
2017-04-03 |
4/A |
A |
$0.00 |
$0 |
I/I |
3,998,534 |
5,255,264 |
0 |
- |
|
| ZLTQ |
Zeltiq Aesthetics Inc |
Director |
– • • |
2012-06-14 |
4 |
B |
$4.79 |
$180,882 |
I/I |
37,727 |
5,288,233 |
2.25 |
- |
|
| ZLTQ |
Zeltiq Aesthetics Inc |
Director |
– • • |
2012-08-02 |
4 |
B |
$4.61 |
$161,452 |
I/I |
35,000 |
5,323,233 |
2.25 |
- |
|
| ZLTQ |
Zeltiq Aesthetics Inc |
Director |
– • • |
2012-08-03 |
4 |
B |
$4.85 |
$24,253 |
I/I |
5,000 |
5,328,233 |
2.17 |
- |
|
| ZLTQ |
Zeltiq Aesthetics Inc |
Director |
– • • |
2012-08-06 |
4 |
B |
$4.89 |
$97,700 |
I/I |
20,000 |
5,348,233 |
2.25 |
- |
|
| ZLTQ |
Zeltiq Aesthetics Inc |
Director |
– • • |
2013-11-14 |
4 |
S |
$12.22 |
$7,026,500 |
I/I |
(575,000) |
5,458,233 |
0 |
- |
|
| ZLTQ |
Zeltiq Aesthetics Inc |
Director |
– • • |
2012-08-07 |
4 |
B |
$5.00 |
$3,423,973 |
I/I |
685,000 |
6,033,233 |
2.25 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Director |
– • • |
2010-02-02 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
8,731,321 |
|
- |
|
122 Records found
|
|
Page 5 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
